MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Panther Fusion® ...
--New assays for the Panther Fusion and Novodiag Systems further build on Hologic’s leading molecular scalable solutions offering to European customers-- The Panther Fusion SARS-CoV-2/Flu A/B/RSV ...
Hologic’s HOLX fully automated, high-throughput Panther platform remains the foundation of its molecular diagnostics business. The Panther Fusion module, a 2016 addition to the base system, provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results